Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Phio Pharmaceuticals Corp. (PHIO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Phio Pharmaceuticals Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1533040.
Total stock buying since 2015: $165,213.
Total stock sales since 2015: $108,112.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 12,700 | $27,011 | 0 | $0 | 0 | $0 |
| 2024 | 4,500 | $3,765 | 0 | $0 | 0 | $0 |
| 2023 | 4,000 | $11,920 | 0 | $0 | 0 | $0 |
| 2022 | 9,716 | $5,745 | 0 | $0 | 0 | $0 |
| 2021 | 11,135 | $24,501 | 0 | $0 | 0 | $0 |
| 2020 | 2,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2017 | 93,500 | $60,247 | 200,000 | $108,112 | 0 | $0 |
| 2015 | 26,000 | $27,024 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 6,000 | $15,015 | 0 | $0 | 0 | $0 |
| 2025-05 | 6,700 | $11,996 | 0 | $0 | 0 | $0 |
| 2024-06 | 2,000 | $1,490 | 0 | $0 | 0 | $0 |
| 2024-02 | 2,500 | $2,275 | 0 | $0 | 0 | $0 |
| 2023-07 | 1,000 | $2,840 | 0 | $0 | 0 | $0 |
| 2023-06 | 3,000 | $9,080 | 0 | $0 | 0 | $0 |
| 2022-12 | 5,000 | $2,039 | 0 | $0 | 0 | $0 |
| 2022-11 | 4,716 | $3,706 | 0 | $0 | 0 | $0 |
| 2021-08 | 6,000 | $9,780 | 0 | $0 | 0 | $0 |
| 2021-03 | 5,135 | $14,721 | 0 | $0 | 0 | $0 |
| 2020-08 | 2,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2017-10 | 10,000 | $4,500 | 0 | $0 | 0 | $0 |
| 2017-09 | 0 | $0 | 200,000 | $108,112 | 0 | $0 |
| 2017-08 | 10,000 | $5,520 | 0 | $0 | 0 | $0 |
| 2017-06 | 13,500 | $8,420 | 0 | $0 | 0 | $0 |
| 2017-04 | 10,000 | $6,480 | 0 | $0 | 0 | $0 |
| 2017-03 | 10,000 | $7,670 | 0 | $0 | 0 | $0 |
| 2017-02 | 20,000 | $13,779 | 0 | $0 | 0 | $0 |
| 2017-01 | 20,000 | $13,878 | 0 | $0 | 0 | $0 |
| 2015-04 | 5,000 | $3,595 | 0 | $0 | 0 | $0 |
| 2015-02 | 6,000 | $7,154 | 0 | $0 | 0 | $0 |
| 2015-01 | 15,000 | $16,275 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-10 | Ferrara Robert L (Director) | Buy | 2,500 | 2.42 | 6,050 |
| 2025-06-10 | Bitterman Robert J (Chairman, Pres & CEO) | Buy | 2,000 | 2.42 | 4,840 |
| 2025-06-09 | Bitterman Robert J (Chairman, Pres & CEO) | Buy | 1,500 | 2.75 | 4,125 |
| 2025-05-22 | Bitterman Robert J (Chairman, Pres & CEO) | Buy | 1,200 | 1.78 | 2,136 |
| 2025-05-21 | Bitterman Robert J (Chairman, Pres & CEO) | Buy | 3,000 | 1.77 | 5,310 |
| 2025-05-20 | Ferrara Robert L (Director) | Buy | 2,500 | 1.82 | 4,550 |
| 2024-06-07 | Bitterman Robert J (President & CEO) | Buy | 1,000 | .74 | 740 |
| 2024-06-06 | Bitterman Robert J (President & CEO) | Buy | 1,000 | .75 | 750 |
| 2024-02-26 | Bitterman Robert J (President & CEO) | Buy | 2,500 | .91 | 2,275 |
| 2023-07-01 | Bitterman Robert J (President & CEO) | Buy | 1,000 | 2.84 | 2,840 |
| 2023-06-30 | Bitterman Robert J (President & CEO) | Buy | 1,000 | 2.88 | 2,880 |
| 2023-06-14 | Ferrara Robert L (Director) | Buy | 2,000 | 3.10 | 6,200 |
| 2022-12-02 | Ferrara Robert L (Director) | Buy | 5,000 | .41 | 2,039 |
| 2022-11-29 | Bitterman Robert J (Interim Executive Chairman) | Buy | 215 | .40 | 86 |
| 2022-11-25 | Bitterman Robert J (Interim Executive Chairman) | Buy | 2,500 | .42 | 1,050 |
| 2022-11-23 | Ferrara Robert L (Director) | Buy | 2,000 | .41 | 820 |
| 2022-11-16 | Bitterman Robert J (Interim Executive Chairman) | Buy | 1 | 1,750.00 | 1,750 |
| 2021-08-16 | Dispersyn Gerrit (President & CEO) | Buy | 6,000 | 1.63 | 9,780 |
| 2021-03-04 | Dispersyn Gerrit (President & CEO) | Buy | 1,953 | 2.56 | 4,999 |
| 2021-03-03 | Ferrara Robert L (Director) | Buy | 682 | 3.15 | 2,148 |
| 2021-03-03 | Dispersyn Gerrit (President & CEO) | Buy | 2,500 | 3.03 | 7,574 |
| 2020-08-19 | Dispersyn Gerrit (President & CEO) | Buy | 2,000 | 2.50 | 5,000 |
| 2017-10-02 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .45 | 4,500 |
| 2017-09-07 | Eliseev Alexey (Chief Business Officer) | Sale | 58,712 | .53 | 30,999 |
| 2017-09-06 | Eliseev Alexey (Chief Business Officer) | Sale | 91,907 | .54 | 49,354 |
| 2017-09-05 | Eliseev Alexey (Chief Business Officer) | Sale | 26,181 | .56 | 14,582 |
| 2017-09-01 | Eliseev Alexey (Chief Business Officer) | Sale | 23,200 | .57 | 13,177 |
| 2017-08-24 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .55 | 5,520 |
| 2017-06-23 | Dispersyn Gerrit (Chief Development Officer) | Buy | 3,500 | .62 | 2,170 |
| 2017-06-22 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .62 | 6,250 |
| 2017-04-26 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .65 | 6,480 |
| 2017-03-17 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .77 | 7,670 |
| 2017-02-17 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .69 | 6,929 |
| 2017-02-08 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .69 | 6,850 |
| 2017-01-25 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .69 | 6,929 |
| 2017-01-19 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | .69 | 6,949 |
| 2015-04-02 | Cauwenbergh Geert (President & CEO) | Buy | 5,000 | .72 | 3,595 |
| 2015-02-17 | Cauwenbergh Geert (President & CEO) | Buy | 4,000 | 1.17 | 4,680 |
| 2015-02-10 | Cauwenbergh Geert (President & CEO) | Buy | 2,000 | 1.24 | 2,474 |
| 2015-01-22 | Bitterman Robert J (Director) | Buy | 5,000 | 1.20 | 5,975 |
| 2015-01-20 | Cauwenbergh Geert (President & CEO) | Buy | 10,000 | 1.03 | 10,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of PHIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Phio Pharmaceuticals Corp. (symbol PHIO, CIK number 1533040) see the Securities and Exchange Commission (SEC) website.